182 related articles for article (PubMed ID: 19755715)
1. Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice.
Utz AC; Hirner H; Blatz A; Hillenbrand A; Schmidt B; Deppert W; Henne-Bruns D; Fischer D; Thal DR; Leithäuser F; Knippschild U
J Histochem Cytochem; 2010 Jan; 58(1):1-15. PubMed ID: 19755715
[TBL] [Abstract][Full Text] [Related]
2. Impaired CK1 delta activity attenuates SV40-induced cellular transformation in vitro and mouse mammary carcinogenesis in vivo.
Hirner H; Günes C; Bischof J; Wolff S; Grothey A; Kühl M; Oswald F; Wegwitz F; Bösl MR; Trauzold A; Henne-Bruns D; Peifer C; Leithäuser F; Deppert W; Knippschild U
PLoS One; 2012; 7(1):e29709. PubMed ID: 22235331
[TBL] [Abstract][Full Text] [Related]
3. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
Shibata MA; Maroulakou IG; Jorcyk CL; Gold LG; Ward JM; Green JE
Cancer Res; 1996 Jul; 56(13):2998-3003. PubMed ID: 8674054
[TBL] [Abstract][Full Text] [Related]
4. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
[TBL] [Abstract][Full Text] [Related]
5. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect.
Goetz F; Tzeng YJ; Guhl E; Merker J; Graessmann M; Graessmann A
Oncogene; 2001 Apr; 20(18):2325-32. PubMed ID: 11402328
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain.
Sakurai E; Kurihara T; Kouchi K; Saegusa H; Zong S; Tanabe T
Mol Pain; 2009 Dec; 5():74. PubMed ID: 20021638
[TBL] [Abstract][Full Text] [Related]
7. 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.
Wu K; Kim HT; Rodriquez JL; Munoz-Medellin D; Mohsin SK; Hilsenbeck SG; Lamph WW; Gottardis MM; Shirley MA; Kuhn JG; Green JE; Brown PH
Clin Cancer Res; 2000 Sep; 6(9):3696-704. PubMed ID: 10999763
[TBL] [Abstract][Full Text] [Related]
8. Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands.
Wang L; Bhattacharyya N; Rabi T; Wang L; Banerjee S
Carcinogenesis; 2007 Jun; 28(6):1356-63. PubMed ID: 17166880
[TBL] [Abstract][Full Text] [Related]
9. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
Yoshidome K; Shibata MA; Couldrey C; Korach KS; Green JE
Cancer Res; 2000 Dec; 60(24):6901-10. PubMed ID: 11156389
[TBL] [Abstract][Full Text] [Related]
10. The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.
Green JE; Shibata MA; Yoshidome K; Liu ML; Jorcyk C; Anver MR; Wigginton J; Wiltrout R; Shibata E; Kaczmarczyk S; Wang W; Liu ZY; Calvo A; Couldrey C
Oncogene; 2000 Feb; 19(8):1020-7. PubMed ID: 10713685
[TBL] [Abstract][Full Text] [Related]
11. Fluctuation of simian virus 40 (SV40) super T-antigen expression in tumors induced by SV40-transformed mouse mammary epithelial cells.
Butel JS; Wong C; Evans BK
J Virol; 1986 Nov; 60(2):817-21. PubMed ID: 3022016
[TBL] [Abstract][Full Text] [Related]
12. Lactation-induced WAP-SV40 Tag transgene expression in C57BL/6J mice leads to mammary carcinoma.
Hüsler MR; Kotopoulis KA; Sundberg JP; Tennent BJ; Kunig SV; Knowles BB
Transgenic Res; 1998 Jul; 7(4):253-63. PubMed ID: 9859214
[TBL] [Abstract][Full Text] [Related]
13. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.
Elson A; Leder P
J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814
[TBL] [Abstract][Full Text] [Related]
14. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
Renner O; Blanco-Aparicio C; Grassow M; Cañamero M; Leal JF; Carnero A
Cancer Res; 2008 Dec; 68(23):9643-53. PubMed ID: 19047141
[TBL] [Abstract][Full Text] [Related]
15. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
Guy CT; Cardiff RD; Muller WJ
Mol Cell Biol; 1992 Mar; 12(3):954-61. PubMed ID: 1312220
[TBL] [Abstract][Full Text] [Related]
16. The SV40 T-antigen induces premature apoptotic mammary gland involution during late pregnancy in transgenic mice.
Tzeng YJ; Gottlob K; Santarelli R; Graessmann A
FEBS Lett; 1996 Feb; 380(3):215-8. PubMed ID: 8601427
[TBL] [Abstract][Full Text] [Related]
17. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
18. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease.
Qiu TH; Chandramouli GV; Hunter KW; Alkharouf NW; Green JE; Liu ET
Cancer Res; 2004 Sep; 64(17):5973-81. PubMed ID: 15342376
[TBL] [Abstract][Full Text] [Related]
19. Mammary gland tumor in transgenic mice expressing targeted beta-casein/HPV16E6 fusion gene.
Hwang DY; Chae KR; Shin DH; Jang IS; Hwang JH; Kim YJ; Cho JY; Kim BJ; Goo JS; Lim CJ; Kim CK; Cho YY; Paik SG; Kim YK; Cho JS
Int J Oncol; 2000 Dec; 17(6):1093-8. PubMed ID: 11078793
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V
Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]